Proposed Requirements for Tobacco Product Manufacturing Practice; Extension of Comment Period, 59481-59482 [2023-18625]

Download as PDF Federal Register / Vol. 88, No. 166 / Tuesday, August 29, 2023 / Proposed Rules authorizations to transition their operations to the applicable operating parts of 14 CFR; and any additional topics interested parties believe should be considered. The FAA will review all comments submitted to inform its planned rulemaking. Issued on August 24, 2023. David H. Boulter, Acting Associate Administrator, Aviation Safety, Federal Aviation Administration. [FR Doc. 2023–18615 Filed 8–28–23; 8:45 am] BILLING CODE 4910–13–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 1120 [Docket No. FDA–2013–N–0227] RIN 0910–AH91 Proposed Requirements for Tobacco Product Manufacturing Practice; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. Proposed rule; extension of comment period. ACTION: The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule entitled ‘‘Requirements for Tobacco Product Manufacturing Practice’’ published in the Federal Register of March 10, 2023, by 30 days. The Agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments. DATES: FDA is extending the comment period on the proposed rule published March 10, 2023 (88 FR 15174), by 30 days. Either electronic or written comments must be submitted by October 6, 2023. ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be considered. The https:// www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of October 6, 2023. Comments received by mail/hand delivery/courier (for written/ paper submissions) will be considered timely if they are received on or before that date. ddrumheller on DSK120RN23PROD with PROPOSALS1 SUMMARY: Electronic Submissions Submit electronic comments in the following way: VerDate Sep<11>2014 16:35 Aug 28, 2023 Jkt 259001 • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2013–N–0227 for ‘‘Requirements for Tobacco Product Manufacturing Practice.’’ Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240–402–7500. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ The Agency will review this copy, including PO 00000 Frm 00011 Fmt 4702 Sfmt 4702 59481 the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https:// www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240–402–7500. FOR FURTHER INFORMATION CONTACT: Matthew Brenner, Center for Tobacco Products, Food and Drug Administration, Document Control Center, 10903 New Hampshire Ave., Bldg. 71, Rm. G335, Silver Spring, MD 20993, 877–287–1373, AskCTPRegulations@fda.hhs.gov. In the Federal Register of March 10, 2023 (88 FR 15174), FDA published a proposed rule entitled ‘‘Requirements for Tobacco Product Manufacturing Practice.’’ The proposed rule provided a 180-day period for submission of public comments. The Agency has received a request for an extension of the comment period for the proposed rule. The request conveyed concern that the comment period does not allow sufficient time to develop a meaningful or thoughtful response to the proposed rule. FDA has considered the request and is extending the comment period for the proposed rule for 30 days, until October 6, 2023. FDA believes this extension is appropriate because of the complexity of the material being posted. The Agency believes that a 30-day extension allows adequate time for interested persons to submit comments. SUPPLEMENTARY INFORMATION: E:\FR\FM\29AUP1.SGM 29AUP1 59482 Federal Register / Vol. 88, No. 166 / Tuesday, August 29, 2023 / Proposed Rules Dated: August 24, 2023. Lauren K. Roth, Associate Commissioner for Policy. for August 30, 2023, at 10 a.m. ET is cancelled. for September 21, 2023, at 10 a.m. ET is cancelled. Oluwafunmilayo A. Taylor, Branch Chief, Publications and Regulations Branch, Associate Chief Counsel, (Procedure & Administration). Oluwafunmilayo A. Taylor, Branch Chief, Publications and Regulations Branch, Associate Chief Counsel, (Procedure & Administration). [FR Doc. 2023–18622 Filed 8–28–23; 8:45 am] [FR Doc. 2023–18626 Filed 8–28–23; 8:45 am] BILLING CODE 4830–01–P BILLING CODE 4830–01–P Internal Revenue Service DEPARTMENT OF THE TREASURY DEPARTMENT OF THE TREASURY 26 CFR Part 1 Internal Revenue Service Alcohol and Tobacco Tax and Trade Bureau [REG–124123–22] 26 CFR Part 1 RIN 1545–BQ57 [REG–106228–22] [FR Doc. 2023–18625 Filed 8–28–23; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF THE TREASURY 27 CFR Part 9 Corporate Bond Yield Curve for Determining Present Value; Hearing Cancellation RIN 1545–BQ61 Internal Revenue Service (IRS), Treasury. ACTION: Cancellation of a public hearing on a proposed rulemaking. AGENCY: This document cancels a public hearing on proposed regulations specifying the methodology for constructing the corporate bond yield curve that is used to derive the interest rates used in calculating present value and making other calculations under a defined benefit plan, as well as for discounting unpaid losses and estimated salvage recoverable of insurance companies. DATES: The public hearing scheduled for August 30, 2023, at 10 a.m. ET is cancelled. SUMMARY: RIN 1513–AD02 Malta Personal Retirement Scheme Listed Transaction; Hearing Cancellation Internal Revenue Service (IRS), Treasury. ACTION: Cancellation of a notice of public hearing on a proposed rulemaking. AGENCY: This document cancels a public hearing on proposed regulations that would identify transactions that are the same as, or substantially similar to, certain Malta personal retirement scheme transactions as listed transactions, a type of reportable transaction. SUMMARY: The public hearing scheduled for September 21, 2023, at 10 a.m. ET is cancelled. DATES: FOR FURTHER INFORMATION CONTACT: FOR FURTHER INFORMATION CONTACT: Vivian Hayes of the Publications and Regulations Branch, Associate Chief Counsel (Procedure and Administration) at (202) 317–6901 (not a toll-free number). Vivian Hayes of the Publications and Regulations Branch, Associate Chief Counsel (Procedure and Administration) at (202) 317–6901 (not a toll-free number). A notice of proposed rulemaking and a notice of public hearing that appeared in the Federal Register on June 23, 2023 (88 FR 41047) announced that a public hearing being held in person and by teleconference was scheduled for August 30, 2023, at 10 a.m. ET. The subject of the public hearing is under 26 CFR part 1. The public comment period for these regulations expired on August 22, 2023. The notice of proposed rulemaking and notice of public hearing instructed those interested in testifying at the public hearing to submit a request to testify and an outline of the topics to be addressed. We did not receive a request to testify at the Public Hearing. Therefore, the public hearing scheduled SUPPLEMENTARY INFORMATION: SUPPLEMENTARY INFORMATION: ddrumheller on DSK120RN23PROD with PROPOSALS1 [Docket No. TTB–2023–0006; Notice No. 224] VerDate Sep<11>2014 16:35 Aug 28, 2023 Jkt 259001 A notice of proposed rulemaking and a notice of public hearing that appeared in the Federal Register on June 7, 2023 (88 FR 37186) announced that a public hearing being held in person and by teleconference was scheduled for September 21, 2023, at 10 a.m. ET. The subject of the public hearing is under 26 CFR part 1. The public comment period for these regulations expired on August 7, 2023. The notice of proposed rulemaking and notice of public hearing instructed those interested in testifying at the public hearing to submit a request to testify and an outline of the topics to be addressed. We did not receive a request to testify at the Public Hearing. Therefore, the public hearing scheduled PO 00000 Frm 00012 Fmt 4702 Sfmt 4702 Proposed Establishment of the Upper Cumberland Viticultural Area Alcohol and Tobacco Tax and Trade Bureau, Treasury. ACTION: Notice of proposed rulemaking. AGENCY: The Alcohol and Tobacco Tax and Trade Bureau (TTB) proposes establishing the approximately 2,186,689 acre ‘‘Upper Cumberland’’ viticultural area in Middle Tennessee. The proposed viticultural area is not within any other established viticultural area. TTB designates viticultural areas to allow vintners to better describe the origin of their wines and to allow consumers to better identify wines they may purchase. TTB invites comments on this proposed addition to its regulations. DATES: Comments must be received by October 30, 2023. ADDRESSES: You may electronically submit comments to TTB on this proposal using the comment form for this document posted within Docket No. TTB–2023–0006 on the Regulations.gov website at https://www.regulations.gov. At the same location, you also may view copies of this document, the related petition and selected supporting materials, and any comments TTB receives on this proposal. A direct link to that docket is available on the TTB website at https://www.ttb.gov/wine/ notices-of-proposed-rulemaking under Notice No. 224. Alternatively, you may submit comments via postal mail to the Director, Regulations and Ruling Division, Alcohol and Tobacco Tax and Trade Bureau, 1310 G Street NW, Box 12, Washington, DC 20005. Please see the Public Participation section of this document for further information on the comments requested on this proposal and on the submission, confidentiality, and public disclosure of comments. SUMMARY: E:\FR\FM\29AUP1.SGM 29AUP1

Agencies

[Federal Register Volume 88, Number 166 (Tuesday, August 29, 2023)]
[Proposed Rules]
[Pages 59481-59482]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18625]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 1120

[Docket No. FDA-2013-N-0227]
RIN 0910-AH91


Proposed Requirements for Tobacco Product Manufacturing Practice; 
Extension of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or the Agency) is 
extending the comment period for the proposed rule entitled 
``Requirements for Tobacco Product Manufacturing Practice'' published 
in the Federal Register of March 10, 2023, by 30 days. The Agency is 
taking this action in response to a request for an extension to allow 
interested persons additional time to submit comments.

DATES: FDA is extending the comment period on the proposed rule 
published March 10, 2023 (88 FR 15174), by 30 days. Either electronic 
or written comments must be submitted by October 6, 2023.

ADDRESSES: You may submit comments as follows. Please note that late, 
untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until 
11:59 p.m. Eastern Time at the end of October 6, 2023. Comments 
received by mail/hand delivery/courier (for written/paper submissions) 
will be considered timely if they are received on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to https://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2013-N-0227 for ``Requirements for Tobacco Product Manufacturing 
Practice.'' Received comments, those filed in a timely manner (see 
ADDRESSES), will be placed in the docket and, except for those 
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. 
and 4 p.m., Monday through Friday, 240-402-7500.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the 
claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on https://www.regulations.gov. 
Submit both copies to the Dockets Management Staff. If you do not wish 
your name and contact information to be made publicly available, you 
can provide this information on the cover sheet and not in the body of 
your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852, 240-402-7500.

FOR FURTHER INFORMATION CONTACT: Matthew Brenner, Center for Tobacco 
Products, Food and Drug Administration, Document Control Center, 10903 
New Hampshire Ave., Bldg. 71, Rm. G335, Silver Spring, MD 20993, 877-
287-1373, [email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of March 10, 2023 
(88 FR 15174), FDA published a proposed rule entitled ``Requirements 
for Tobacco Product Manufacturing Practice.'' The proposed rule 
provided a 180-day period for submission of public comments.
    The Agency has received a request for an extension of the comment 
period for the proposed rule. The request conveyed concern that the 
comment period does not allow sufficient time to develop a meaningful 
or thoughtful response to the proposed rule.
    FDA has considered the request and is extending the comment period 
for the proposed rule for 30 days, until October 6, 2023. FDA believes 
this extension is appropriate because of the complexity of the material 
being posted. The Agency believes that a 30-day extension allows 
adequate time for interested persons to submit comments.


[[Page 59482]]


    Dated: August 24, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-18625 Filed 8-28-23; 8:45 am]
BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.